← Leaderboards
Mark G. Alexandrow
H. Lee Moffitt Cancer Ctr & Res Inst
$3,618,805
Attributed
$3,618,805
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $520.5K · FY2010–24$1M$750K$500K$250K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$3,618,805 · 4
By mechanism
R01$2,812,314 · 2
R21$806,491 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsMalignant NeoplasmsBiochemicalMolecularProteinsDna BiosynthesisEnzymesAtp HydrolysisMediatingComplexTumorigenesisSiteHelicaseS PhaseMutantCancer CellDrug DevelopmentBaseChromatinFuturePublic Health RelevanceCell Cycle ProgressionBindingIn Vitro
Grant awards (13)
Direct Control of the human CMG Helicase by Myc and Rb$329,400
R01 · FY2024 · GM · contact PI
Direct Control of the human CMG Helicase by Myc and Rb$329,400
R01 · FY2023 · GM · contact PI
Direct Control of the human CMG Helicase by Myc and Rb$329,400
R01 · FY2022 · GM · contact PI
Direct Control of the human CMG Helicase by Myc and Rb$329,400
R01 · FY2021 · GM · contact PI
Inhibition of the CMG Helicase as Novel Anti-Neoplastic Approach$187,050
R21 · FY2017 · CA · contact PI
Inhibition of the CMG Helicase as Novel Anti-Neoplastic Approach$219,893
R21 · FY2016 · CA · contact PI
Chromatin Remodeling by Cdt1: Role in DNA Replication and Tumorigenesis$293,441
R01 · FY2014 · CA · contact PI
Chromatin Remodeling by Cdt1: Role in DNA Replication and Tumorigenesis$284,366
R01 · FY2013 · CA · contact PI
Chromatin Remodeling by Cdt1: Role in DNA Replication and Tumorigenesis$302,517
R01 · FY2012 · CA · contact PI
MCM Helicase as a Novel Target for Pancreatic Cancer Treatment$181,613
R21 · FY2012 · CA · contact PI
Chromatin Remodeling by Cdt1: Role in DNA Replication and Tumorigenesis$302,517
R01 · FY2011 · CA · contact PI
MCM Helicase as a Novel Target for Pancreatic Cancer Treatment$217,935
R21 · FY2011 · CA · contact PI
Chromatin Remodeling by Cdt1: Role in DNA Replication and Tumorigenesis$311,873
R01 · FY2010 · CA · contact PI